| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-14 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-09 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-09 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |